United Therapeutics | UTHR - 股票



金融业
股票价格
USD 541.51
资产
USD 7.22B
现金及等价物
USD 1.8B
销售成本
USD 99.5M
流动资产
USD 3.48B
流动负债
USD 607.8M
债务
USD 200M
EBIT
USD 375.6M
EBITDA
USD 355M
员工
1.31K
EPS每股收益
USD 7.27
股本和储备
USD 6.4B
销售毛利
USD 683.8M
债务利息支出
USD 2.9M
利息收入
USD 31.5M
贷款资金
USD 100M
市值
USD 25.79B
净收入
USD 333M
营业费用
USD 6.4B
营业利润
USD 330.8M
普通股股本
USD 42.68M
PE价格收益
19.15
税前利润
USD 372.7M
销售收入
USD 783.3M
销售和管理费用
USD 206.7M
股票
USD 193.8M
贸易债权人
USD 497.8M
应收帐款人
USD 310.3M


股票 更改 日
Amarin USD 164.07M 19.51M 2026-06
Ardelyx USD 128.02M 110.29M 2026-03
Baxter International USD 2.26B 57M 2026-06
Bayer EUR 11.97B 43M 2026-06
BioCryst Pharmaceuticals USD 6.06M 71K 2026-06
Biogen USD 2.38B 435.3M 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Emergent BioSolutions USD 328.9M 25.2M 2023-12
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Halozyme Therapeutics USD 137.14M 18.33M 2026-06
Insmed USD 142.38M 9.48M 2026-06
Ionis Pharmaceuticals USD 50.83M 45.28M 2026-06
J&J USD 15.14B 561M 2026-06
Lexicon Pharmaceuticals USD 276K 5K 2026-03
Moderna USD 280M 134M 2026-06
Omeros USD 712K 266K 2021-09
Pfizer USD 9.94B 722M 2026-06
PTC Therapeutics USD 91.35M 15.79M 2026-06
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
Teva Pharmaceutical Industries USD 3.18B 3M 2026-03
United Therapeutics USD 193.8M 15.5M 2026-06
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06